<DOC>
	<DOCNO>NCT00047762</DOCNO>
	<brief_summary>The purpose study test safety Tarceva , find best dose , see effect ( good bad ) colorectal cancer . The effect Tarceva evaluate combination 5-fluorouracil , leucovorin , irinotecan , without Bevacizumab .</brief_summary>
	<brief_title>Safety , Efficacy , Pharmacokinetics Study Tarceva Treat Advanced Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Erlotinib Hydrochloride</mesh_term>
	<criteria>Subjects must fulfill follow criterion eligible study entry : Signed informed consent At least 18 year age Histologically confirm metastatic colorectal adenocarcinoma colon rectum Resected biopsied primary tumor metastatic site serve basis histologic confirmation . Measurable disease ( define least one dimension &gt; 2 cm [ &gt; 1 cm spiral CT scan ] ) ECOG performance status 0 1 Life expectancy &gt; 3 month Use effective mean contraception men woman childbearing potential Ability comply study followup procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2004</verification_date>
</DOC>